INTRA-CELLULAR THERAPIES, INC.

Organization · NY
Hires government relations

Biopharmaceutical company

Who they hire

2024 · 2 filings · Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
$██,███ / qtrUnlock

What they lobby on

HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Health Issues · 2024 Q2
HR 3938: Build it in America Act - Provisions regarding research and development tax amortization. S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax amortization.
Taxation/Internal Revenue Code · 2024 Q2
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception. H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Provisions regarding reforms to the Inflation Reduction Act (IRA). Part D 6 protected classes policy. Medicaid Drug Rebate Program Rule - Provisions regarding "stacking" of rebates and discounts.
Medicare/Medicaid · 2024 Q2
HR 3938/S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax credit amortization.
Taxation/Internal Revenue Code · 2024 Q1